A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma
Clinical trial NCT06226350 · COMPLETED
Trial details
- NCT number
- NCT06226350
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2023-12-05
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.